AhR agonist 2 is a triazolopyridine derivative and novel aryl hydrocarbon receptor (AhR) agonist with the advantages of being orally bioavailable and highly potent (EC50=0.03 nM), inducing rapid nuclear enrichment of the AhR and facilitating skin barrier repair for the treatment of psoriasis.
Molecular Weight:
353.01
Formula:
C12H7Br2N3
Target:
AhR|||Aryl Hydrocarbon Receptor
T61244
* VAT and and shipping costs not included. Errors and price changes excepted
